Seclidemstat in the treatment of Ewing sarcoma and other select sarcomas

  • STATUS
    Recruiting
  • sponsor
    Salarius Pharmaceuticals
Updated on 4 February 2022

Summary

If you are eligible and agree to participate, you will receive the investigational (called "study") medication. Whether you receive the study medication alone or with another type of 'standard of care' treatment will depend on your type of sarcoma. The study doctor/staff will talk with you more about this.

You will take the study medication twice a day throughout the study. If you also receive 'standard of care' treatment, you will be given intravenous (needle inserted into a vein) infusions on a certain schedule, which is dependent upon the type of sarcoma you have.

You may continue participating in this study as long as you remain eligible and are benefiting from taking the study medication. Even if the study ends while you are participating, you may still be eligible to receive the study medication.

Description

All study-related visits, tests, and medications that are not part of your standard sarcoma treatment will be provided to you at no cost. Reimbursement for study-related travel may also be provided.

Learn more at our study website or on clinicaltrials.gov:

Details
Condition Sarcoma, Sarcoma (Pediatric), Ewing's Family Tumors, Ewing Sarcoma
Clinical Study IdentifierTX291188
SponsorSalarius Pharmaceuticals
Last Modified on4 February 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Be 12 years of age or older
Have been diagnosed with Ewing sarcoma or sarcoma that is related to Ewing sarcoma
Sarcoma must have returned or not responded to treatment
Have received at least 1 prior therapy for sarcoma
Additional eligibility criteria will apply
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note